Further restructuring at Cardinal?
Cardinal Health’s announcement that it is considering spinning off some of its divisions has provoked fevered speculation among industry analysts and media observers alike.
Cardinal Health’s announcement that it is considering spinning off some of its divisions has provoked fevered speculation among industry analysts and media observers alike.
The impact counterfeit pharmaceuticals can have on a company’s sales has been highlighted by Tongjitang Chinese Medicines’ (TCM) second quarter results.
The US Food and Drug Administration (FDA) has issued a warning letter to contract manufacturer G&W Laboratories.
The US Pharmacopeia (USP) has continued to expand its global reach by opening a site in São Paulo, Brazil; its first in Latin America.
CRO Rubicon Research and chemicals manufacturer Mallinckrodt Baker are teaming up to develop the PanExcea excipient range, which was launched by the latter firm’s parent company Covidien in July.
Conformia says that the integration of its SOA data platform into IBM’s system will provide drugmakers with robust management architecture for the entire lifecycle of a product.